Dr. Karin Hehenberger, aa ati. Setting the Stage EVP & CMO, Coronado Biosciences Dr. William A. Haseltine, President, ACCESS Health International Dr. Martin Fitchet, COO, Janssen Research & Development 9:20a.m. Welcoming Remarks . . ; Professor Kerstin Brismar, Ailtslnal, Paeseinenm, Karolinska Institutet Chairma